skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 915,716  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Oncology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Tumor-Infiltrating Natural Killer Cells
Tumor-Infiltrating Natural Killer Cells
Material Type:
Article 		Add to My Research

Tumor-Infiltrating Natural Killer Cells

Cancer discovery, 2021-01, Vol.11 (1), p.34-44

2020 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-20-0655 ;PMID: 33277307

Full text available

Citations Cited by
2
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Material Type:
Article 		Add to My Research

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Journal of clinical oncology, 2020-01, Vol.38 (1), p.1-10 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02105 ;PMID: 31682550

Full text available

Citations Cited by
3
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Material Type:
Article 		Add to My Research

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2020-01, Vol.38 (3), p.193-202 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01307 ;PMID: 31790344

Full text available

Citations Cited by
4
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
Material Type:
Article 		Add to My Research

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Journal of clinical oncology, 2019-04, Vol.37 (10) [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.18.00306

Full text available

Citations Cited by
5
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer
Material Type:
Article 		Add to My Research

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer

Clinical cancer research, 2020-10, Vol.26 (20), p.5310-5319 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-1764 ;PMID: 32694159

Full text available

Citations Cited by
6
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Material Type:
Article 		Add to My Research

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Journal of clinical oncology, 2021-06, Vol.39 (18), p.JCO2003175-1970 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03175 ;PMID: 33739857

Full text available

Citations Cited by
7
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Material Type:
Article 		Add to My Research

Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer

Cancer discovery, 2020-09, Vol.10 (9), p.1330-1351

Copyright ©2020, American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-19-1384 ;PMID: 32434947

Full text available

Citations Cited by
8
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
Material Type:
Article 		Add to My Research

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.3077-3083 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.2591 ;PMID: 30016178

Full text available

Citations Cited by
9
The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis
The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis
Material Type:
Article 		Add to My Research

The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.291-303 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-19-1181 ;PMID: 31727628

Full text available

Citations Cited by
10
ROS and diseases: role in metabolism and energy supply
ROS and diseases: role in metabolism and energy supply
Material Type:
Article 		Add to My Research

ROS and diseases: role in metabolism and energy supply

Molecular and cellular biochemistry, 2020-04, Vol.467 (1-2), p.1-12 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2019 ;COPYRIGHT 2020 Springer ;Molecular and Cellular Biochemistry is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0300-8177 ;EISSN: 1573-4919 ;DOI: 10.1007/s11010-019-03667-9 ;PMID: 31813106

Full text available

Citations Cited by
11
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Material Type:
Article 		Add to My Research

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Clinical cancer research, 2019-08, Vol.25 (16), p.5002-5014 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-3524 ;PMID: 30837276

Full text available

Citations Cited by
12
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer
Material Type:
Article 		Add to My Research

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2017-12, Vol.35 (34), p.3867-3876 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.74.7642 ;PMID: 29053400

Full text available

Citations Cited by
13
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Material Type:
Article 		Add to My Research

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-06, Vol.22 (12), p.2908-2918 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-15-2412 ;PMID: 26787752

Full text available

Citations Cited by
14
TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma
TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma
Material Type:
Article 		Add to My Research

TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma

Clinical cancer research, 2018-11, Vol.24 (22), p.5710-5723 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-0163 ;PMID: 29764856

Full text available

Citations Cited by
15
LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity
LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity
Material Type:
Article 		Add to My Research

LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16), p.4786-4789 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-18-0125 ;PMID: 29959149

Full text available

Citations Cited by
16
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
Material Type:
Article 		Add to My Research

TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)

Clinical cancer research, 2019-11, Vol.25 (22), p.6788-6800 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-0126 ;PMID: 31481512

Full text available

Citations Cited by
17
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Material Type:
Article 		Add to My Research

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2022-10, Vol.33 (10), p.1005-1020 [Peer Reviewed Journal]

2022 European Society for Medical Oncology ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2022.07.004

Full text available

Citations Cited by
18
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Material Type:
Article 		Add to My Research

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Annals of oncology, 2021-12, Vol.32 (12), p.1475-1495 [Peer Reviewed Journal]

2021 European Society for Medical Oncology ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.09.019

Full text available

Citations Cited by
19
Progresses Toward Precision Medicine in RET -altered Solid Tumors
Progresses Toward Precision Medicine in RET -altered Solid Tumors
Material Type:
Article 		Add to My Research

Progresses Toward Precision Medicine in RET -altered Solid Tumors

Clinical cancer research, 2020-12, Vol.26 (23), p.6102-6111 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-1587 ;PMID: 32665298

Full text available

Citations Cited by
20
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
Material Type:
Article 		Add to My Research

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes

Cancer research (Chicago, Ill.), 2018-09, Vol.78 (18), p.5259-5273 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-17-3058 ;PMID: 30042152

Full text available

Citations Cited by

Results 1 - 20 of 915,716  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (811,246)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1964  (6,239)
  2. 1964 To 1978  (18,093)
  3. 1979 To 1993  (65,666)
  4. 1994 To 2009  (208,460)
  5. After 2009  (618,324)
  6. More options open sub menu

Subject 

  1. Science & Technology  (913,457)
  2. Life Sciences & Biomedicine  (910,917)
  3. Humans  (550,056)
  4. Female  (306,410)
  5. Male  (234,294)
  6. Middle Aged  (192,154)
  7. Tumors  (190,049)
  8. Biological And Medical Sciences  (181,386)
  9. Medical Sciences  (167,593)
  10. Aged  (156,248)
  11. Adult  (155,197)
  12. Animals  (154,381)
  13. Cancer  (127,795)
  14. Cancer Research  (112,646)
  15. Medicine  (107,538)
  16. Medicine & Public Health  (101,557)
  17. Prognosis  (99,785)
  18. Chemotherapy  (92,475)
  19. Mice  (89,869)
  20. More options open sub menu

Language 

  1. English  (914,865)
  2. Japanese  (121,249)
  3. Portuguese  (1,501)
  4. Polish  (866)
  5. Turkish  (703)
  6. Spanish  (694)
  7. Norwegian  (592)
  8. German  (531)
  9. Chinese  (309)
  10. Russian  (266)
  11. Korean  (251)
  12. French  (227)
  13. Slovenian  (24)
  14. Italian  (11)
  15. Afrikaans  (5)
  16. Dutch  (4)
  17. Danish  (2)
  18. Serbian  (1)
  19. Catalan  (1)
  20. Swedish  (1)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait